←
Tyler Seibert MD PhD3,157 posts
Tyler Seibert MD PhD avatar✓

Tyler Seibert MD PhD ✓

@TylerSbrt

#radonc and #cancer scientist @UCSanDiego. Quantitative MRI. Genetic risk. Clinical trials. SeibertLab.com Joined 2019. Hacked 2026; lost all followers😒

◷ Joined April 2026▧ 273 Photos and videos
Simon C avatar
⟳ Tyler Seibert MD PhD retweeted
Simon C@scserendipity1·11h

We are formed Open Medicine to be a free resource for the World! My clever fellow founder AG said let’s build the ‘Wikipedia of medicine’… I wasn’t convinced but with our wonderful clinical faculty and my other founder EK and his software team providing support it is happening Thank you @iamnephrologist thank you Open Medicine Foundation Circle! @DrChoueiri (our number 1) @neerajaiims @VincentRK @StephenVLiu @drallysonocean @drallysonocean @KapoorNitinDr @AzadOncology @cpeedell @AlisonBirtle @brian_rini @CharuAggarwalMD @shilpaonc @Dr_R_Kurzrock @OpenMedKate @drsarahsam @scocmem @BalazsHalmosMD @OncoThor

Darren Poon avatar
⟳ Tyler Seibert MD PhD retweeted
Darren Poon@DrDarrenPoon·19h

🎉 Excited to share our newly published SRAM trial results in Radiotherapy and Oncology (Green Journal)! 🔬 Our SRAM randomized phase II trial (NCT03938649) compared once-weekly, 5-fraction prostate and pelvic SBRT with conventional IMRT in patients with node-negative, high-risk prostate cancer. 📊 Key findings (121 patients): ✅ No significant difference in grade ≥2 GI and GU toxicity at 6–12 months. ✅ Comparable urinary quality of life. ⚠️ Greater deterioration in patient-reported bowel quality of life following SBRT at 9–12 months. 💡 Clinical Takeaway: 🚀 Five-fraction pelvic SBRT offers a promising, substantially shorter treatment approach, but convenience must not come at the expense of bowel quality of life. 🎯 Physician-graded toxicity alone may miss clinically meaningful symptoms. Optimizing rectal dose constraints and incorporating patient-reported outcomes are essential as we refine pelvic SBRT protocols. 📖 Publication: Radiotherapy and Oncology, Volume 226 (2027), Article 111870 📅 Published online: 11 November 2026 📋 Trial registration: NCT03938649 🔗 doi.org/10.1016/j.radonc.202… #ProstateCancer #SBRT #RadiationOncology #ClinicalResearch @ESTRO_RT @HKSUO_hk @BarbaraJereczek @PBlanchardMD @RO_GreenJournal @PaulSargos @alison_tree @VedangMurthy @Xristodouleas @DrAndrewLoblaw @alongi_filippo @_ShankarSiva @SbrtSean @DrSACooper @PCaParker @ChadTangMD @jryckman3 @APCCC_Lugano @HimanshuNagarMD @I_Migowski @AmarUKishan @DrSpratticus

Simon C avatar
⟳ Tyler Seibert MD PhD retweeted
Simon C@scserendipity1·13h

Brilliant photo Washington to Boston this morning

Post attachmentPost attachment
Nikita Sushentsev avatar
⟳ Tyler Seibert MD PhD retweeted
Nikita Sushentsev@NikiSushentsev·Nov 17

Separating the wheat from the chaff to SIMPLIFY reporting is in everyone’s interest, particularly at biopsy. How many pts denied AS due to minute volume of poorly formed GP4 which half would call GP3? Morphologies that do most harm are the least ambiguous - more data soon!

Simon C avatar
⟳ Tyler Seibert MD PhD retweeted
Simon C@scserendipity1·Nov 17

Sad to leave Washington but returning to one of my spiritual homes. Boston. A city where my family are @ChowdhuryLab both official and adopted @DrChoueiri @neerajaiims Sadly won’t see Toni. But he has been such a supporter of me both personally and professionally. My latest venture Open Medicine @OpenMedInsights has launched successfully and we now have over 100 of the very best doctors in medicine in our Foundation Circle. The first person to sign up was Toni! Thank you TC. @DanaFarber #BostonStrong @PTarantinoMD @DrHBurstein @drsarahsam @montypal @stolaney1 @VanAllenLab Take a look at this video, 'shipping up to boston' share.google/klxDaG7vcWBwEDk…

Jane K Nguyen MD PhD avatar
⟳ Tyler Seibert MD PhD retweeted
Jane K Nguyen MD PhD@JaneNguyen44·Nov 16

Yes, opens up the discussion about making decisions off lesions with pathological uncertainty and where amount of P4 and type of P4 play important roles. The term on pbx of borderline histology has helped us tremendously better risk stratify these patients. @ZSchwen @MWatfa26

Jim Hu avatar
⟳ Tyler Seibert MD PhD retweeted
Jim Hu@jimhumd·Nov 16

1/8 🧵 A small prostate. Systematic + MRI-targeted biopsy. Less than 1 mm of GG1 cancer. Decipher 0.17. Eleven months later: GG4 on repeat biopsy, followed by EPE and a positive margin at prostatectomy. Did we miss aggressive cancer—or did it progress this quickly? We are debating whether GG1 should even be called “cancer.” 🧵 @PCF_Science @PCFnews @urotoday @AmericanCancer @AmerUrological nytimes.com/2023/08/30/opini…

Post attachmentPost attachment
Samson W. Fine, MD avatar
⟳ Tyler Seibert MD PhD retweeted
Samson W. Fine, MD@rovingatuscap·Nov 16

#5 Would ML/AI help with Grading & Quantification in a focus like this? - AI depends on the annotations models were trained with - threshold/watershed areas of morphology and minute foci could be expected to be as difficult for an AI product as for pathologists (IMO)

Samson W. Fine, MD avatar
⟳ Tyler Seibert MD PhD retweeted
Samson W. Fine, MD@rovingatuscap·Nov 16

At this time - overly detailed/confusing outputs from LLMs aside - it is also unlikely that existing ML/AI digital diagnostics can handle the communication aspects in a case such as this - Thanks to all for engaging!

Fumiko Ladd Chino, MD, FASCO avatar
⟳ Tyler Seibert MD PhD retweeted
Fumiko Ladd Chino, MD, FASCO@fumikochino·Nov 15

Let's just say you're spending extra time in Nashville due to airport shutdowns and eat a delightful breakfast at a local diner. If the person who happens to be sitting next to you at the counter is also a #radonc, you know it's definitely @Uromigos #UromigosLive week.

Post attachment
Kara Watts avatar
⟳ Tyler Seibert MD PhD retweeted
Kara Watts@KaraWattsMD·Nov 15

Incredibly grateful for the amazing experience and invitation to speak at #SMU26. 3 days filled with inspiring lectures and brilliant Urologists/MDs from around the world, as well as the most incredible hosts. 🙏Thank you to @AlexHermen @smumexico!

Post attachmentPost attachmentPost attachmentPost attachment